Search

everythinglearnresearchcommunity

for

Search:↓

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

The triple rotation scalp flap technique successfully reconstructed a man's scalp with natural-looking hair growth and minimal scarring.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

About 61% of women who had COVID-19 experienced hair loss afterward.

Middle-aged and elderly men with BPH had higher hospitalization rates for COVID-19.

Certain eye surgery complications can be managed effectively, especially in patients who have used specific prostate medications.

Frontalis suspension surgery using autologous fascia lata is effective for treating unilateral congenital ptosis with poor levator function.

Removing lymph nodes does not improve survival for advanced ovarian cancer and may cause more complications.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

A woman with severe hair loss due to systemic sclerosis regrew her hair in 4 months using a combination of treatments.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

Possible link between androgens and COVID-19 severity; more research needed.

Extra virgin olive oil may boost the immune system and help fight infections like COVID-19.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Hair loss doesn't affect COVID-19 severity.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Many women with HIV in the North of England are diagnosed late and have other health conditions.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Opioid painkillers can cause many side effects, including breathing problems and addiction, but are generally considered safe when used properly.